Goldman Sachs is forecasting these ASX dividend shares to provide income investors with big dividend yields in the near ...

Up 25% in 12 months, a leading fundie sees strong ongoing growth potential for this S&P/ASX 300 Index (ASX: XKO) stock.

Let's run the numbers and see how much an Australian investor would need in their superannuation fund to live off $65,000 a ...

Investing $1,000 a month with an average total return of 12% per annum would grow into $2.15 million after 27 years. That ...

Last week, the broker reaffirmed its buy rating and $40.20 price target on the ASX 200 share. This implies potential upside ...

Let's see why its analysts are so bullish on these stocks this year. You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a ...

The S&P/ASX 200 Index (ASX: XJO) is up 3% in 2025, with these three ASX 200 stocks doing a lot of the heavy lifting.

This S&P/ASX 300 Index (ASX: XKO) tech stock has delivered by strong returns in the last few years. Here’s why there could be ...

Kogan.com Ltd (ASX: KGN) and Regis Resources Ltd (ASX: RRL) are two of four ASX shares falling on Friday. Here's ...

We reveal the forecast dividend amounts and dividend yields that analysts expect the largest ASX 200 financial shares to pay ...

Goldman has a buy rating and $40.20 price target on its shares. Another ASX 200 share that is being described as a fallen ...

ASX healthcare stocks are in the green on Friday, with the S&P/ASX 200 Health Care Index (ASX: XHJ) currently 0.41% higher.